Myriad Genetics buy DerAlmanach100000
Start price
23.11.25
/
100%
€6.30
Target price
23.11.28
-
Performance (%)
-23.49%
Price
27.01.26
€4.82
Summary
This prediction is currently active. The price of Myriad Genetics has decreased since the start of the prediction. Compared to the start price this results in a performance of -23.49%. This prediction currently runs until 23.11.28. The prediction end date can be changed by DerAlmanach100000 at any time. DerAlmanach100000 has 100% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Myriad Genetics | -4.854% | -4.854% |
| iShares Core DAX® | -0.121% | 2.507% |
| iShares Nasdaq 100 | 0.081% | -0.241% |
| iShares Nikkei 225® | -1.748% | 4.105% |
| iShares S&P 500 | -0.961% | -0.143% |
According to DerAlmanach100000 what are the pros and cons of Myriad Genetics for the foreseeable future?
Pros
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Undervalued
Very Future proof/growth oriented business model
Market Leader or Top 3